The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Transitioning ifosfamide based chemotherapy to the outpatient setting: A model of implementation of transitioning chemotherapy outpatient in a safety net hospital.
 
Cindy Banh
No Relationships to Disclose
 
Alejandra Arrendondo
No Relationships to Disclose
 
Kassie Notbohm
No Relationships to Disclose
 
Kendall Valsvik
No Relationships to Disclose
 
Alicia Ortega
No Relationships to Disclose
 
Lauren Sanders
No Relationships to Disclose
 
Alejandro Recio
No Relationships to Disclose
 
Andrew Kraft
No Relationships to Disclose
 
Hani M. Babiker
Consulting or Advisory Role - Celgene; Endocyte; Idera; Myovant Sciences
Speakers' Bureau - Guardant Health
 
Brian Do
No Relationships to Disclose
 
Daniel O Persky
Consulting or Advisory Role - Bayer; Celgene; Cellectar; Debiopharm Group; Epizyme; Karyopharm Therapeutics; kymera; MorphoSys
Research Funding - Merck (Inst)
 
Ivo Abraham
Stock and Other Ownership Interests - Matrix45; Matrix45 (I)
 
Ali McBride
Consulting or Advisory Role - EMD Serono; Pfizer; Sandoz
Speakers' Bureau - Bristol-Myers Squibb; Coherus Biosciences; Incyte